AIM
LJPC

Advantage Investment Management’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Advantage Investment Management’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$9K Hold
1,000
– – 0.01% 678
2019
Q2 		$9K Hold
1,000
– – 0.01% 686
2019
Q1 		$6K Buy
+1,000
New +$6.51K ﹤0.01% 749

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VMI
VHCP Management III New York $504M AUM 683.12% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Advantage Investment Management's LJPC Position: Q3 2019 in Review

Advantage Investment Management held its La Jolla Pharmaceutical Company (LJPC) position steady in Q3 2019 at 1,000 shares worth $9K. The position accounts for 0.01% of the portfolio, ranked #678.

Advantage Investment Management first reported a position in LJPC in Q1 2019 and has held it in 3 quarters since. 75 funds tracked by Wall St. Rank hold LJPC as of Q3 2019.

  • Advantage Investment Management held 1,000 shares of La Jolla Pharmaceutical Company worth $9K as of Q3 2019.
  • Advantage Investment Management left its La Jolla Pharmaceutical Company share count unchanged in Q3 2019.
  • La Jolla Pharmaceutical Company made up 0.01% of Advantage Investment Management's portfolio in Q3 2019, its #678 holding.
  • Advantage Investment Management first reported a position in La Jolla Pharmaceutical Company in Q1 2019 and has held it in 3 quarters since.
  • 75 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q3 2019.

Based on Advantage Investment Management's 13F filing for Q3 2019, filed 8 Oct 2019.